BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8264689)

  • 1. Anti-GM1 antibodies and impaired blood-nerve barrier may interfere with remyelination in multifocal motor neuropathy.
    Kaji R; Hirota N; Oka N; Kohara N; Watanabe T; Nishio T; Kimura J
    Muscle Nerve; 1994 Jan; 17(1):108-10. PubMed ID: 8264689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do GM1 antibodies induce demyelination?
    Lange DJ; Trojaborg W
    Muscle Nerve; 1994 Jan; 17(1):105-7. PubMed ID: 8264688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [On the mechanisms and diagnosis of conduction disturbances due to demyelination with special reference to multifocal demyelinating neuropathy (Lewis-Sumner)].
    Kaji R; Kimura J
    Rinsho Shinkeigaku; 1991 Dec; 31(12):1330-2. PubMed ID: 1817801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motor neuropathies and antiglycolipid antibodies.
    Serratrice G
    Clin Exp Neurol; 1993; 30():25-32. PubMed ID: 7712626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demyelinating symmetric motor polyneuropathy with high titers of anti-GM1 antibodies.
    O'Ferrall EK; White CM; Zochodne DW
    Muscle Nerve; 2010 Oct; 42(4):604-8. PubMed ID: 20730877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiganglioside antibodies do not necessarily play a role in multifocal motor neuropathy.
    Parry GJ
    Muscle Nerve; 1994 Jan; 17(1):97-9. PubMed ID: 8264709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and diagnostic role of anti-GM1 antibody testing.
    Kornberg AJ; Pestronk A
    Muscle Nerve; 1994 Jan; 17(1):100-4. PubMed ID: 8264687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibodies to GM1 ganglioside in motor neuron disease--in comparison with demyelinating neuropathy].
    Irie S; Saito T; Ogino M; Ito H; Kowa H
    Rinsho Shinkeigaku; 1992 Oct; 32(10):1075-80. PubMed ID: 1297550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower motor neuron syndrome associated with anti-GM1 antibodies.
    Villa A; Molina H; Sanz OP; Garreto N; Kholer G; Sica RE
    Medicina (B Aires); 1997; 57(3):270-4. PubMed ID: 9640758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical correlates of high-titer IgG anti-GM1 antibodies.
    Kornberg AJ; Pestronk A; Bieser K; Ho TW; McKhann GM; Wu HS; Jiang Z
    Ann Neurol; 1994 Feb; 35(2):234-7. PubMed ID: 8109905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multifocal motor neuropathies with persistent conduction blocks: a form of inflammatory demyelinating neuropathy].
    Pouget J; Azulay JP; Boucraut J
    Rev Neurol (Paris); 1996 May; 152(5):370-4. PubMed ID: 8881432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invited review: motor neuropathies, motor neuron disorders, and antiglycolipid antibodies.
    Pestronk A
    Muscle Nerve; 1991 Oct; 14(10):927-36. PubMed ID: 1658646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Measurement of antiganglioside autoantibodies by immunodot-blot assay: clinical importance in peripheral neuropathies].
    Caudie C; Vial C; Petiot P; Bancel J; Later R; Gonnaud PM
    Ann Biol Clin (Paris); 1999; 57(5):579-88. PubMed ID: 10518060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multifocal-motor neuropathy and motor neuropathy with multifocal conduction block (Lewis-Sumner syndrome)].
    Finsterer J; Mamoli B
    Wien Klin Wochenschr; 1995; 107(10):301-8. PubMed ID: 7785276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anti-ganglioside antibodies and motor neuropathy in relation to nerve conduction block].
    Kaji R; Nishio T; Bara W; Mesaki T; Matsui H; Akiguchi I; Kimura J
    No To Shinkei; 1992 Aug; 44(8):691-8. PubMed ID: 1419346
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical correlations of anti-GM1 antibodies in amyotrophic lateral sclerosis and neuropathies.
    Lamb NL; Patten BM
    Muscle Nerve; 1991 Oct; 14(10):1021-7. PubMed ID: 1944401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies.
    Pestronk A; Chaudhry V; Feldman EL; Griffin JW; Cornblath DR; Denys EH; Glasberg M; Kuncl RW; Olney RK; Yee WC
    Ann Neurol; 1990 Mar; 27(3):316-26. PubMed ID: 2327739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].
    Younes-Chennoufi AB; Baumann N
    Rev Neurol (Paris); 1996 May; 152(5):375-9. PubMed ID: 8881433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of testing for anti-GM1 antibodies.
    McCombe PA; Wilson R; Prentice RL
    J Clin Neurosci; 2000 May; 7(3):209-12. PubMed ID: 10833617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgM deposits at nodes of Ranvier in a patient with amyotrophic lateral sclerosis, anti-GM1 antibodies, and multifocal motor conduction block.
    Santoro M; Thomas FP; Fink ME; Lange DJ; Uncini A; Wadia NH; Latov N; Hays AP
    Ann Neurol; 1990 Sep; 28(3):373-7. PubMed ID: 2132741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.